GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/MASE for Severe GERD After Sleeve Gastrectomy: AES | September 2026
10

MASE for Severe GERD After Sleeve Gastrectomy: AES | September 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated September 1, 2026

Conventional Approach:

GERD after laparoscopic sleeve gastrectomy (LSG) can be difficult to manage because the fundus has been resected, gastric geometry is altered, and intragastric pressure may increase. PPIs remain first-line therapy, while severe refractory reflux may require surgical conversion, commonly to Roux-en-Y gastric bypass.

Why was a new technique needed?

Conventional fundoplication is difficult after sleeve gastrectomy because of the absence of an intact fundus.

Some patients have persistent reflux despite optimized medical therapy.

Revisional bariatric surgery is effective but considerably more invasive.

This creates a potential therapeutic space for anatomy-adapted endoscopic anti-reflux procedures.

New Technique: MASE

MASE (Mucosal Ablation and Suturing of the Esophagogastric Junction) combines targeted mucosal ablation at the gastric cardia with full-thickness endoscopic suturing. Cinching the treated tissue promotes remodeling and creates a tighter, reinforced gastroesophageal junction. Importantly, the procedure can be performed through an antegrade, forward-viewing approach and does not require an intact gastric fundus.

Clinical Utility:

MASE may offer a minimally invasive option for selected patients with refractory GERD after sleeve gastrectomy.

Its main advantage is applicability in altered post-surgical anatomy where fundoplication-based techniques may not be feasible.

Other emerging approaches include ARMA/ARMS and endoscopic suturing techniques.

Patient selection should consider anatomy, reflux mechanism, physiology, hiatal anatomy, and previous bariatric surgery.

Evidence remains limited, and long-term comparative efficacy and durability require further study.

Take-home Message:

Post-sleeve GERD may require an anatomy-specific rather than one-size-fits-all approach. MASE offers a promising endoscopic option for selected patients with altered anatomy, but its precise role relative to medical therapy and revisional surgery remains to be established.

Related Q&A

11

ASGE Technology Update - ESD Is Expanding Rapidly in Western Practice: GIE | August 2026

ntroduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large superficial GI neoplasia, allowing accurate histopathology and potentially curative R0 resection while avoiding surgery. This ASGE technology...

12

Do All Elderly Patients With Asymptomatic Bile-Duct Stones Need ERCP?: CGH | August 2026

Introduction: Guidelines generally favor removal of common bile-duct stones because of the future risk of cholangitis, pancreatitis, and obstruction. However, in elderly patients, the balance is less straightforward...

13

EUS-Guided Coil + Cyanoacrylate vs TIPS for Gastric Variceal Bleeding: Endoscopy | August 2026

Introduction: Gastric variceal bleeding (GVB) is a high-risk portal hypertensive emergency in which conventional endoscopic therapy may be inadequate. EUS-guided coil embolisation plus cyanoacrylate (EUS-Coils+CYA) offers targeted variceal...

14

Fluoroscopy-Free Cholangioscopy for Bile-Duct Stones: GIE | August 2026

Introduction: Conventional ERCP relies on fluoroscopy for biliary imaging and stone extraction, exposing patients and endoscopy teams to ionising radiation. Fluoroscopy-free direct solitary cholangioscopy (DSC) offers direct intraductal...

15

Salvaging a Transcolonic EUS-Gastroenterostomy Misdeployment With a Stent-in-Stent Technique: GIE | August 2026

Conventional Method: EUS-guided gastroenterostomy (EUS-GE) creates a bypass between the stomach and jejunum using a lumen-apposing metal stent (LAMS) for malignant gastric outlet obstruction. Successful deployment requires a...

16

ERCP for Bile Duct Stones: Frontline Gastroenterology | August 2026

Introduction: ERCP remains central to the management of common bile duct (CBD) stones, with established BSG and ESGE recommendations guiding patient selection, difficult stone management, and prevention of...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer